Can Allergan Bounce Again?
ThinkstockPharmaceutical giant Allergan Inc. (NYSE: AGN) saw its stock climb to an all-time high of more than $116 a share in April before slipping, sliding, stumbling and crashing to below $85 last night. At…
ThinkstockPharmaceutical giant Allergan Inc. (NYSE: AGN) saw its stock climb to an all-time high of more than $116 a share in April before slipping, sliding, stumbling and crashing to below $85 last night. At…
ThinkstockIt is just as bad being a child living in Mississippi as it is being an adult. The same holds true for most other states in the Deep South, including Louisiana, South Carolina and…
ThinkstockTenet Healthcare Corp. (NYSE: THC) this morning announced that it has agreed to acquire Vanguard Health Systems Inc. (NYSE: VHS) for $21 a share in cash. The deal is valued at $4.3 billion, which…
ThinkstockConsultancy PwC expects medical costs to rise at only 6.5% in 2014, which would be down sharply from increases in recent years. It expects the both the economy and federal public policy will help…
ThinkstockThe analysts at Lazard Capital continue to believe that underlying fundamentals for the top companies in the drug channel (distributors, retailers, etc.) remain sound. Prescription use has picked up over the past six months,…
Courtesy Herbalife Ltd.U.S. Representative Linda Sanchez has sent a letter to the Federal Trade Commission (FTC) requesting that the agency begin an investigation into allegations that Herbalife Ltd. (NYSE: HLF) is a pyramid scheme.…
ThinkstockIn 2012, the S&P 500 Healthcare Equipment & Supply index was up 15.1%, while the S&P 500 was up 13.4%. However, it was in-line with the broader S&P 500 Healthcare index, which was up…
ThinkstockThe U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body. In its ruling, the court also ruled that synthetic molecules called complementary DNA (cDNA)…
ThinkstockA new communication has been issued by the U.S. Food & Drug Administration (FDA) for medical device manufacturers. This may sound like it is out of a science fiction movie, but the threat is…
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems like an…
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference between not…
ThinkstockAmbit Biosciences Corp. (NASDAQ: AMBI) has been somewhat tame since its recent initial public offering (IPO). Its quiet period has ended and the analyst community is looking past a poor post-IPO performance with very…
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their coverage universe to find the best opportunities. They…
ThinkstockUnitedHealth Group, Inc. (NYSE: UNH) is the largest health insurance provider in America. That makes it a number one target of the so-called affordable health care, or Obamacare, along with the other health insurance…
ThinkstockAnother company IPO filing has been on Monday from Cellular Dynamics International, Inc. No financial terms have been set, but the filing is for up to $57,250,000 worth of common sock. The company has…